Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (921-930 of 4,104) with videos related to

Pageof 411
Sort By:
Cancer Cell|February 21, 2025
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer modelsPatrizia Porazzi, Siena Nason, Ziqi Yang, et al.
Cancer Cell|February 11, 2025
Genomic mediators of acquired resistance to immunotherapy in metastatic melanomaJulia Schiantarelli, Mouadh Benamar, Jihye Park, et al.
Cancer Cell|January 31, 2025
Circulating T cells fuel anti-PD-1 and lenvatinib efficacyPeter J Matulich, Megan L Burger
Cancer Cell|November 15, 2024
Itaconate promotes an unexpected tumor immune escape mechanismLara Haase, Christian Frezza
Cancer Cell|November 1, 2024
Targeting DLK1 in neuroblastomaJohn Anderson
Cancer Cell|November 1, 2024
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trialDiwakar Davar, Robert M Morrison, Amiran K Dzutsev, et al.
Cancer Cell|November 1, 2024
Intratumoral vidutolimod in combination with PD-1 blockade in locoregionally advanced melanomaJames W Smithy, Michael A Postow
Cancer Cell|November 8, 2024
Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistanceHeng Lin, Kole Tison, Yuheng Du, et al.
Cancer Cell|March 21, 2025
Horizontal mitochondrial transfer in cancer biology: Potential clinical relevanceMichael V Berridge, Renata Zobalova, Stepana Boukalova, et al.
Cancer Cell|March 14, 2025
PAI-1-driven SFRP2<sup>high</sup> cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapyYan-Pei Zhang, Ze-Qin Guo, Xiao-Ting Cai, et al.
Pageof 411

Showing results (921-930 of 4,104) with videos related to

Sort By:
Pageof 411
Cancer Cell|February 21, 2025
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer modelsPatrizia Porazzi, Siena Nason, Ziqi Yang, et al.
Cancer Cell|February 11, 2025
Genomic mediators of acquired resistance to immunotherapy in metastatic melanomaJulia Schiantarelli, Mouadh Benamar, Jihye Park, et al.
Cancer Cell|January 31, 2025
Circulating T cells fuel anti-PD-1 and lenvatinib efficacyPeter J Matulich, Megan L Burger
Cancer Cell|November 15, 2024
Itaconate promotes an unexpected tumor immune escape mechanismLara Haase, Christian Frezza
Cancer Cell|November 1, 2024
Targeting DLK1 in neuroblastomaJohn Anderson
Cancer Cell|November 1, 2024
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trialDiwakar Davar, Robert M Morrison, Amiran K Dzutsev, et al.
Cancer Cell|November 1, 2024
Intratumoral vidutolimod in combination with PD-1 blockade in locoregionally advanced melanomaJames W Smithy, Michael A Postow
Cancer Cell|November 8, 2024
Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistanceHeng Lin, Kole Tison, Yuheng Du, et al.
Cancer Cell|March 21, 2025
Horizontal mitochondrial transfer in cancer biology: Potential clinical relevanceMichael V Berridge, Renata Zobalova, Stepana Boukalova, et al.
Cancer Cell|March 14, 2025
PAI-1-driven SFRP2<sup>high</sup> cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapyYan-Pei Zhang, Ze-Qin Guo, Xiao-Ting Cai, et al.
Pageof 411